Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment
Although progress has been indeed made by nanomedicines, their efficacies for cancer treatment remain low, consequently leading to failures in translation to clinic. To improve the drug delivery efficiency, nanoparticles need to change size so as to fully utilize the enhanced permeability and retent...
Saved in:
Main Authors: | Rui Liu (Author), Chuan Hu (Author), Yuanyuan Yang (Author), Jingqing Zhang (Author), Huile Gao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Photothermally responsive theranostic nanocomposites for near‐infrared light triggered drug release and enhanced synergism of photothermo‐chemotherapy for gastric cancer
by: Taicheng Zhou, et al.
Published: (2023) -
Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy
by: Yun Yang, et al.
Published: (2022) -
A cleavable self-delivery nanoparticle for tumor photo-immunotherapy
by: Chuan Hu, et al.
Published: (2021) -
GSH-Triggered/Photothermal-Enhanced H<sub>2</sub>S Signaling Molecule Release for Gas Therapy
by: Xinqiang Liang, et al.
Published: (2023) -
Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal/chemodynamic combined ferroptosis therapy treating gastric cancer
by: Zhian Chen, et al.
Published: (2022)